| Impact of BRCA Mutation Status on Tumor Infiltrating Lymphocytes (TILs), Response to Treatment, and Prognosis in Breast Cancer Patients Treated with … B Grandal, C Evrevin, E Laas, I Jardin, S Rozette, L Laot, E Dumas, ... Cancers 12 (12), 3681, 2020 | 18 | 2020 |
| Multimodal prediction of five-year breast Cancer recurrence in women who receive Neoadjuvant chemotherapy S Rabinovici-Cohen, XM Fernández, B Grandal Rejo, E Hexter, ... Cancers 14 (16), 3848, 2022 | 14 | 2022 |
| Laparoscopy during pregnancy: case report and key points to improve laparoscopic management J Estadella, P Español, B Grandal, M Gine, J Parra European Journal of Obstetrics & Gynecology and Reproductive Biology 217, 83-88, 2017 | 14 | 2017 |
| PD-L1 expression after neoadjuvant chemotherapy in triple-negative breast cancers is associated with aggressive residual disease, suggesting a potential for immunotherapy B Grandal, M Mangiardi-Veltin, E Laas, M Laé, D Meseure, G Bataillon, ... Cancers 13 (4), 746, 2021 | 12 | 2021 |
| Text mining in electronic medical records enables quick and efficient identification of pregnancy cases occurring after breast cancer J Labrosse, T Lam, C Sebbag, M Benque, I Abdennebi, H Merckelbagh, ... JCO clinical cancer informatics 3, 1-12, 2019 | 11 | 2019 |
| Comedications influence immune infiltration and pathological response to neoadjuvant chemotherapy in breast cancer AS Hamy, L Derosa, C Valdelièvre, S Yonekura, P Opolon, M Priour, ... OncoImmunology 9 (1), 1677427, 2020 | 10 | 2020 |
| Time to pregnancy, obstetrical and neonatal outcomes after breast cancer: a study from the Maternity Network for Young Breast Cancer Patients J Labrosse, A Lecourt, A Hours, C Sebbag, A Toussaint, E Laas, F Coussy, ... Cancers 13 (5), 1070, 2021 | 8 | 2021 |
| The prognostic value of lymph node involvement after neoadjuvant chemotherapy is different among breast cancer subtypes L Laot, E Laas, N Girard, E Dumas, E Daoud, B Grandal, JY Pierga, ... Cancers 13 (2), 171, 2021 | 8 | 2021 |
| The French Early Breast Cancer Cohort (FRESH): a resource for breast cancer research and evaluations of oncology practices based on the French National Healthcare System … E Dumas, L Laot, F Coussy, B Grandal Rejo, E Daoud, E Laas, A Kassara, ... Cancers 14 (11), 2671, 2022 | 7 | 2022 |
| Radiomics for predicting response to neoadjuvant chemotherapy treatment in breast cancer S Rabinovici-Cohen, T Tlusty, A Abutbul, K Antila, X Fernandez, BG Rejo, ... Medical imaging 2020: imaging informatics for healthcare, research, and …, 2020 | 6 | 2020 |
| Evolution of synchronous female bilateral breast cancers and response to treatment AS Hamy, J Abécassis, K Driouch, L Darrigues, M Vandenbogaert, ... Nature Medicine 29 (3), 646-655, 2023 | 5 | 2023 |
| Breast cancer (BC) is a window of opportunity for smoking cessation: Results of a retrospective analysis of 1234 BC survivors in follow-up consultation M Nicolas, B Grandal, E Dubost, A Kassara, J Guerin, A Toussaint, E Laas, ... Cancers 13 (10), 2423, 2021 | 5 | 2021 |
| HER2-Positive Breast Cancer Patients with Pre-Treatment Axillary Involvement or Postmenopausal Status Benefit from Neoadjuvant Rather than Adjuvant … E Laas, A Bresset, JG Féron, C Le Gal, L Darrigues, F Coussy, B Grandal, ... Cancers 13 (3), 370, 2021 | 4 | 2021 |
| No impact of smoking status on breast cancer tumor infiltrating lymphocytes, response to neoadjuvant chemotherapy and prognosis V Simon, L Laot, E Laas, S Rozette, J Guerin, T Balezeau, M Nicolas, ... Cancers 12 (10), 2943, 2020 | 4 | 2020 |
| Impact of the area of residence of ovarian cancer patients on overall survival F Jochum, AS Hamy, T Gaillard, L Lecointre, P Gougis, É Dumas, ... Cancers 14 (23), 5987, 2022 | 3 | 2022 |
| Early prediction of metastasis in women with locally advanced breast cancer S Rabinovici-Cohen, T Tlusty, XM Fernández, BG Rejo Medical Imaging 2022: Computer-Aided Diagnosis 12033, 106-115, 2022 | 3 | 2022 |
| Rethinking surgical revisions: impact of the MonarchE trial on axillary dissection in hormone-positive HER2-negative early breast cancer patients potentially eligible for … T Gaillard, J Piketty, JG Feron, N Girard, L Pauly, E Gauroy, L Darrigues, ... British Journal of Cancer, 1-8, 2024 | 2 | 2024 |
| Treatments During Pregnancy Targeting ERBB2 and Outcomes of Pregnant Individuals and Newborns P Gougis, B Grandal, F Jochum, K Bihan, F Coussy, S Barraud, ... JAMA Network Open 6 (10), e2339934-e2339934, 2023 | 2 | 2023 |
| Factors Associated With the Discussion of Fertility Preservation in a Cohort of 1,357 Young Breast Cancer Patients Receiving Chemotherapy A Hours, A Toussaint, V De Castelbajac, C Sautter, J Borghese, S Frank, ... Frontiers in Oncology 11, 701620, 2021 | 2 | 2021 |
| Immune Checkpoint Inhibitor Use During Pregnancy and Outcomes in Pregnant Individuals and Newborns P Gougis, AS Hamy, F Jochum, K Bihan, M Carbonnel, JE Salem, ... JAMA Network Open 7 (4), e245625-e245625, 2024 | 1 | 2024 |
